![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reliance Gen. | LSE:GMX | London | Ordinary Share | GB00B1MM9925 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.55 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:3936P GeneMedix PLC 04 September 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS AVS NO All relevant boxes should be completed in block capital letters. 1. Name of company 2. Name of director GENEMEDIX PLC Dr Hong-Hoi Ting 3. Please state whether notification 4. Name of the registered holder(s) and, if indicates that it is in respect of more than one holder, the number of shares holding of the shareholder named in held by each of them (if notified) 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest Shares held directly by Dr Hong Hoi Dr Hong-Hoi Ting Ting 5. Please state whether notification 6. Please state the nature of the relates to a person(s) connected transaction. For PEP transactions please with the director named in 2 above indicate whether general/single and identify the connected person co PEP and if discretionary/non (s) discretionary /non discretionary N/A Market disposals 7. Number of 8. Percentage of 9. Number of shares/ 10. Percentage of shares/amount issued class amount of stock issued class of stock disposed acquired N/A N/A 1,240,000 0.42% 11. Class of 12. Price per 13. Date of 14. Date company security share transaction informed ORDINARY 15.5p-19.9p 19 JUNE 2003-27 2 SEPTEMBER 2003 SHARES OF 1P (see below) AUG 2003 (SEE EACH BELOW) 15. Total holding following this 16. Total percentage holding of issued class notification following this notification 17,326,820 5.79% If a director has been granted options by the company please complete the following boxes. 17. Date of grant 18. Period during which or date on which exercisable 19. Total amount paid (if any) for 20. Description of shares or debentures grant of the option involved: class, number 21. Exercise price (if fixed at time of 22. Total number of shares or debentures over grant) or indication that price is which options held following this to be fixed at time of exercise notification 23. Any additional information 24. Name of contact and telephone number for queries THESE DISPOSALS WERE MADE BY DR JULIAN ATTFIELD, CHIEF FINANCIAL OFFICER TING'S STOCKBROKER WITHOUT HIS KNOWLEDGE AND DR TING ONLY BECAME AWARE OF THESE DISPOSALS ON 1 SEPTEMBER 2003. 01638 663320 25. Name and signature of authorised company official responsible for making this notification Date of notification 4 September 2003 Details of Dr Ting's share dealings covered by this Schedule 11: 19-Jun-03 20,000 18.00p 30-Jun-03 10,000 16.00p 11-Jul-03 30,000 16.00p 15-Jul-03 50,000 19.41p 16-Jul-03 30,000 16.00p 16-Jul-03 50,000 19.86p 17-Jul-03 30,000 19.54p 18-Jul-03 50,000 19.41p 28-Jul-03 100,000 18.14p 30-Jul-03 100,000 18.00p 31-Jul-03 61,000 17.79p 01-Aug-03 50,000 15.50p 01-Aug-03 12,000 17.47p 04-Aug-03 50,000 15.50p 12-Aug-03 38,000 16.92p 13-Aug-03 34,000 17.08p 14-Aug-03 157,000 17.45p 15-Aug-03 75,000 17.43p 18-Aug-03 100,000 17.82p 19-Aug-03 75,000 17.76p 20-Aug-03 50,000 17.65p 21-Aug-03 18,000 17.85p 27-Aug-03 50,000 15.50p This information is provided by RNS The company news service from the London Stock Exchange END RDSILFVLARISIIV
1 Year Reliance Genemedix Chart |
1 Month Reliance Genemedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions